Wordt geladen...
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
BACKGROUND: Although progress in children, in adults, ALL still carries a dismal outcome. Here, we explored the in vitro and in vivo activity of PF-00477736 (Pfizer), a potent, selective ATP-competitive small-molecule inhibitor of checkpoint kinase 1 (Chk1) and with lower efficacy of checkpoint kina...
Bewaard in:
Gepubliceerd in: | J Hematol Oncol |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BioMed Central
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635624/ https://ncbi.nlm.nih.gov/pubmed/26542114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0206-5 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|